<p>Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma</p>-Reference-Cited by-同舟云学术

Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma

Published:2020-03 Issue: Volume:Volume 14 Page:885-896
ISSN:1177-5483
Container-title:Clinical Ophthalmology
language:en
Short-container-title:OPTH

Author:

Martin Patrick^ORCID,Cohen Alisa,Uddin Sharif^ORCID,Epelbaum Laura,Josiah Serene

Publisher

Informa UK Limited

Subject

Ophthalmology

Reference23 articles.

1. Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040

2. Primary Open-Angle Glaucoma Suspect Preferred Practice Pattern® Guidelines

3. Extracellular matrix in the trabecular meshwork: Intraocular pressure regulation and dysregulation in glaucoma

4. Aqueous outflow - A continuum from trabecular meshwork to episcleral veins

5. The Dysfunction of the Trabecular Meshwork During Glaucoma Course

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current trends and prospects of the local antihypertensive drugs development for the glaucoma treatment;Russian Ophthalmological Journal;2024-07-02

2. Peptide-Based Therapeutics and Drug Delivery Systems;Drugs and a Methodological Compendium;2023

3. Current situation and progress of drugs for reducing intraocular pressure;Therapeutic Advances in Chronic Disease;2022-01

4. Glaucoma Clinical Research: Trends in Treatment Strategies and Drug Development;Frontiers in Medicine;2021-09-13

5. Therapeutic Peptides Targeting PPI in Clinical Development: Overview, Mechanism of Action and Perspectives;Frontiers in Molecular Biosciences;2021-06-14